Bentham Science Publishers logo

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

Volume 3, Number 1, February 2004
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Book review

Review article

5-HT1 Receptors
pp. 1-10(10)
Authors: Lanfumey L.; Hamon M.

5-HT2 Receptors
pp. 11-26(16)
Author: Leysen J.E.

5-HT3 Receptors
pp. 27-37(11)
Authors: Costall B.; Naylor R.J.

5-HT4 Receptors
pp. 39-51(13)
Authors: Bockaert J.; Claeysen S.; Compan V.; Dumuis A.

5-HT5 Receptors
pp. 53-58(6)
Author: Nelson D.L.

5-ht6 Receptors
pp. 59-79(21)
Authors: Woolley M.L.; Marsden C.A.; Fone K.C.F.

5-HT7 Receptors
pp. 81-90(10)
Authors: Thomas D.R.; Hagan J.J.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A